about
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancersThe prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapyHigh immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.On the origin of myeloid-derived suppressor cells.Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis.Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy.Association of Chemokines and Chemokine Receptor Expression with Monocytic-Myeloid-Derived Suppressor Cells during Tumor Progression.Mathematical Analysis of Cytokine-Induced Differentiation of Granulocyte-Monocyte Progenitor Cells
P2860
Q36494634-03D8C115-5B19-4219-9EE0-569F6E20F50FQ36729376-6568D2E5-8DCF-4514-BEB9-ED36465B09DBQ37336207-6298C231-6D5E-4716-BC8C-B511AA688C87Q37376414-1E5C8474-FE35-4EA8-B87E-BE7176536884Q38748299-9562D3C2-7B5D-4033-82E2-95535AFE3133Q38811369-66A6752F-0B50-4EAA-8C4E-A9B9DCE34DA3Q38968944-C1F5665C-9D6A-430A-87AD-D465C8E95CF7Q39178061-F4DC4E5A-AF96-4C31-8C24-134F8EEF1B0EQ47098690-4E3BB8FE-1B8C-4A6A-B099-8B968A10EE8AQ47150917-22FFAF30-5420-4B38-B18E-05D2AC9D3A0DQ55511990-C366CA0C-F978-42EF-8318-F1A7CEC70515Q55516375-3587FF75-9222-4624-9D8C-FAABFD3E7D27Q57073717-01926E92-6A0D-4A1E-ADC3-7D58D3330774
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular pathways: myeloid complicity in cancer.
@ast
Molecular pathways: myeloid complicity in cancer.
@en
Molecular pathways: myeloid complicity in cancer.
@nl
type
label
Molecular pathways: myeloid complicity in cancer.
@ast
Molecular pathways: myeloid complicity in cancer.
@en
Molecular pathways: myeloid complicity in cancer.
@nl
prefLabel
Molecular pathways: myeloid complicity in cancer.
@ast
Molecular pathways: myeloid complicity in cancer.
@en
Molecular pathways: myeloid complicity in cancer.
@nl
P2860
P1476
Molecular pathways: myeloid complicity in cancer.
@en
P2093
Ingunn M Stromnes
Philip D Greenberg
P2860
P304
P356
10.1158/1078-0432.CCR-13-0866
P407
P577
2014-07-21T00:00:00Z